Skip to content

CHINA BCT PHARMACY GROUP, INC.: 10-Q filed 2012-11-15

What CHINA BCT PHARMACY GROUP, INC. reported in its quarterly report filed 2012-11-15 (fiscal Q3 2012): 38 published measures, 100 facts as tagged in accession 0001213900-12-006242.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-15
Fiscal period
fiscal Q3 2012
Accession
0001213900-12-006242 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All CHINA BCT PHARMACY GROUP, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-30236,587,818USD
At 2011-12-31212,582,449USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-09-3067,568,053USD
At 2011-12-3162,676,335USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-3019,367,354USD
At 2011-12-3131,479,528USD
At 2011-09-3034,263,735USD
At 2010-12-3120,157,112USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-10,736,409USD274
2011-01-01 to 2011-09-30-4,840,804USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-09-302,593,919USD274
2011-01-01 to 2011-09-301,887,074USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-07-01 to 2012-09-3055,402,769USD92
2012-01-01 to 2012-09-30187,746,088USD274
2011-07-01 to 2011-09-3067,480,712USD92
2011-01-01 to 2011-09-30191,199,700USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-301,392,332USD274
2011-01-01 to 2011-09-3022,879,309USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-2,878,966USD274
2011-01-01 to 2011-09-30-5,224,201USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-3098,156,271USD
At 2011-12-3182,448,134USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-3019,859,886USD
At 2011-12-3118,097,062USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-166,006USD92
2012-01-01 to 2012-09-30471,452USD274
2011-07-01 to 2011-09-30-2,822USD92
2011-01-01 to 2011-09-30574,136USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-305,824,458USD92
2012-01-01 to 2012-09-3026,503,433USD274
2011-07-01 to 2011-09-3012,453,242USD92
2011-01-01 to 2011-09-3032,701,904USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-30194,240,642USD
At 2011-12-31172,086,814USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-09-3067,256,350USD
At 2011-12-3162,101,209USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-09-3045,611,582USD
At 2011-12-3142,290,191USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2012-09-30542,248USD
At 2011-12-31540,157USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-09-30142,273,600USD
At 2011-12-31118,406,001USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-304,923,692USD92
2012-01-01 to 2012-09-3014,107,985USD274
2011-07-01 to 2011-09-303,847,121USD92
2011-01-01 to 2011-09-3013,278,320USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-09-3018,782,283USD
At 2011-12-3114,183,052USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-3010,748,150USD92
2012-01-01 to 2012-09-3040,611,418USD274
2011-07-01 to 2011-09-3016,300,363USD92
2011-01-01 to 2011-09-3045,980,224USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-3038,154,340shares
At 2011-12-3138,154,340shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-09-3018,745,218USD
At 2011-12-3118,273,766USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-09-309,560,934USD
At 2011-12-318,909,155USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-09-30133,351,579USD
At 2011-12-31116,520,211USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2012-09-30229,099USD
At 2011-12-312,015,307USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-09-3025,311,128USD
At 2011-12-3121,288,802USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-09-305,451,242USD
At 2011-12-314,511,548USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-09-30439,582USD
At 2011-12-31504,948USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-07-01 to 2012-09-304,152,823USD92
2012-01-01 to 2012-09-3019,490,420USD274
2011-07-01 to 2011-09-309,457,540USD92
2011-01-01 to 2011-09-3024,309,966USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-302,873,312USD92
2012-01-01 to 2012-09-3015,708,137USD274
2011-07-01 to 2011-09-308,290,529USD92
2011-01-01 to 2011-09-3021,586,940USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-302,567,242USD92
2012-01-01 to 2012-09-307,188,885USD274
2011-07-01 to 2011-09-302,127,195USD92
2011-01-01 to 2011-09-307,843,247USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-07-01 to 2012-09-30421,786USD92
2012-01-01 to 2012-09-301,234,769USD274
2011-07-01 to 2011-09-30448,609USD92
2011-01-01 to 2011-09-301,141,687USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-01-01 to 2012-09-3065,815USD274
2011-01-01 to 2011-09-3073,528USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-144,351USD92
2012-01-01 to 2012-09-30-241,120USD274
2011-07-01 to 2011-09-30170,137USD92
2011-01-01 to 2011-09-30501,421USD273

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,527,284USD92
2012-01-01 to 2012-09-306,771,893USD274
2011-07-01 to 2011-09-303,165,839USD92
2011-01-01 to 2011-09-308,893,359USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2012-01-01 to 2012-09-3048,658USD274
2011-01-01 to 2011-09-30-4,133USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-3023,338,452USD274
2011-01-01 to 2011-09-3030,174,501USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-304,542,253USD274
2011-01-01 to 2011-09-302,025,584USD273

Inspect the source

Entity
CHINA BCT PHARMACY GROUP, INC. / CIK 0001399356
Captured
SEC response SHA-256
46435f5c28061b6a8f3140bbabb65cebb6700810bb95cd58ce891609ce2c6d12

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001399356.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))